Issn Print: 1462-0324
Publication Date: 2017/08/17
Serious infection risk after 1 year between patients with rheumatoid arthritis treated with rituximab or with a second TNFi after initial TNFi failure: results from The British Society for Rheumatology Biologics Register for Rheumatoid Arthritis
Lucía Silva-Fernández; Diederik De Cock; Mark Lunt; Audrey S. Low; Kath D. Watson; Deborah P. M. Symmons; Kimme L. Hyrich
Author Information: Arthritis Research UK Centre for Epidemiology, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK
|Checking for direct PDF access through Ovid|
Abstract unavailable for this article.